FDA Approval: FLUORESCITE (FLUORESCEIN SODIUM) — Type 5 - New Formulation or New Manufacturer
Policy FDA-NDA021980 · Ophthalmology
Fluorescite (Fluorescein Sodium) is approved as an injectable drug, which suggests it will qualify for a J-code assignment for Medicare billing. As an injectable and likely high-cost therapy, it may b